Details for New Drug Application (NDA): 083733
✉ Email this page to a colleague
NDA 083733 describes PYRIDAMAL 100, which is a drug marketed by Bel Mar and is included in one NDA. Additional details are available on the PYRIDAMAL 100 profile page.
The generic ingredient in PYRIDAMAL 100 is chlorpheniramine maleate. There are twenty-nine drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the chlorpheniramine maleate profile page.
The generic ingredient in PYRIDAMAL 100 is chlorpheniramine maleate. There are twenty-nine drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the chlorpheniramine maleate profile page.
Summary for 083733
| Tradename: | PYRIDAMAL 100 |
| Applicant: | Bel Mar |
| Ingredient: | chlorpheniramine maleate |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 083733
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 100MG/ML | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
